Uterine Fibroid Treatment Market
According to Intent Market Research, the Uterine Fibroid Treatment Market is expected to grow from USD 4.2 billion in 2024-e at a CAGR of 9.0% to touch USD 7.6 billion by 2030. The Uterine Fibroid Treatment Market is dominated by key players such as AbbVie, Bayer AG, Johnson & Johnson, Merck & Co. and GSK (GlaxoSmithKline).